Format

Send to

Choose Destination
See comment in PubMed Commons below
Biom J. 2009 Oct;51(5):749-62. doi: 10.1002/bimj.200800190.

Statistical tests based on new composite hypotheses in clinical trials reflecting the relative clinical importance of multiple endpoints quantitatively.

Author information

1
Department of Technology Assessment and Biostatistics, National Institute of Public Health, 3-6 Minami 2 chome, Wako, Saitama 351-0197, Japan. mnishikawa@niph.go.jp

Abstract

In clinical trials, several endpoints (EPs) are often evaluated to compare treatments in some therapeutic area. Suppose that there are two EPs in a clinical trial. We propose a new set of composite hypotheses for continuous variables, taking the relative clinical importance of the EPs into account. The main hypotheses were formulated to show that a treatment is so superior to the control treatment, which is not necessarily a placebo, in one EP, that the possible non-inferiority of the treatment by at most a certain value in the other EP can be compensated sufficiently, taking the clinical point of view into account. The maximum non-inferiority margin of one EP might not be a biologically unimportant difference in exchange for much superiority of the other EP. This formulation leads to a new composite EP and a very simple test statistic. The intersection-union principle was employed to derive the proposed test.

PMID:
19777463
DOI:
10.1002/bimj.200800190
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center